Product Information

BRIMONIDINE-TIMOLOL 0.2%-0.5% is a generic product labeled by Leading Pharma, LLC, priced at $1.8390 per ML under NDC 69315033015. Its NADAC has been published 52 times since Aug 27, 2025.

FDA first approved this application on Feb 25, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE-TIMOLOL 0.2%-0.5%

Brimonidine Tartrate and Timolol Maleate
$1.8390per ML

Strength

2; 5 mg/mL; mg/mL

NDC

69315033015

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA219093

FDA Approved

2/25/2025

TE Code

AB

On Market Since

5/29/2025

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has been published 52 times since Aug 27, 2025, and over the history we have for it it has declined 72.3%. The table below summarizes its recorded NADAC range and movement.

Current price$1.8390 per ML
All-time high$6.8975 (Oct 15, 2025)
All-time low$1.8390 (Aug 19, 2026)
52-week high$6.8975
52-week low$1.8390
Median price$2.5305
Average price$3.8688
Largest weekly change-35.8% (Dec 17, 2025)
Weeks tracked52
Tracking sinceAug 27, 2025

Price History

1W

-4.8%

1M

-4.8%

3M

-22.8%

6M

-27.3%

1Y

N/A

3Y

N/A

5Y

N/A

All

-72.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BRIMONIDINE-TIMOLOL 0.2%-0.5%?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE-TIMOLOL 0.2%-0.5%, manufactured by Leading Pharma, LLC, is $1.8390 per ML (NDC 69315033015), effective Aug 19, 2026.

How has the price of BRIMONIDINE-TIMOLOL 0.2%-0.5% changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has declined 72.3%. It has been tracked across 52 weekly CMS publications since Aug 27, 2025.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Since Aug 27, 2025, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has ranged from a low of $1.8390 (Aug 19, 2026) to a high of $6.8975 (Oct 15, 2025), with a median of $2.5305 per ML.

Are there cheaper alternatives to BRIMONIDINE-TIMOLOL 0.2%-0.5%?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BRIMONIDINE-TIMOLOL 0.2%-0.5% in a comparable dosage form, but none are currently priced below it.

Who manufactures BRIMONIDINE-TIMOLOL 0.2%-0.5%?

BRIMONIDINE-TIMOLOL 0.2%-0.5% (NDC 69315033015) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.